P25: A hidden target for AD therapeutic.

  • Ha, Il-Ho (Institute for Brain Science and Technology(IBST) and Graduate Program in Neuroscience, Inje University)
  • Published : 2006.04.26

Abstract

P25/CDK5 phosphorylates BACE1. 2. P25 is a new target for AD therapeutics. 3. P25 inhibitors should block both $A{\beta}$ pathway and Tau pathway.

Keywords